Home/Clear Scientific/Winston Henderson, JD

WH

Winston Henderson, JD

General Counsel

Clear Scientific

Therapeutic Areas

Substance Use Disorder & Overdose Metabolic Disorders Neurodegenerative Diseases

Clear Scientific Pipeline

Drug	Indication	Phase
Overdose Reversal (Methamphetamine/Fentanyl)	Drug Overdose Reversal	Pre-clinical
Metabolic/CNS Dysfunction	Conditions caused by excess harmful metabolites	Pre-clinical

Leadership Team at Clear Scientific

Chief Executive Officer

EVP, Drug Development

John Marota, MD, PhD

Medical Director

Chief Financial Officer

Mitch Zakin, PhD

EVP, Innovation

View full Clear Scientific profile